IMNN Imunon, Inc.
Healthcare$2.20+0.00%ClosedMarket Cap: $5.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.29
P/S
0.00
EV/EBITDA
-0.12
DCF Value
$3.08
FCF Yield
-271.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-341.2%
ROA
-182.6%
ROIC
-346.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-4.3M | $-4.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.3M | $-4.2M | $— | — |
| FY null | $0.00 | NaN% | $-14.7M | $-14.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.5M | $-3.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.8M | $-2.7M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-4.1M | $-4.1M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.1M | $-4.1M | $— | — |
| FY null | $0.00 | NaN% | $-19.1M | $-18.6M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-5.0M | $-4.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.0M | $-4.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.0M | $-4.9M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-6.0M | $-4.9M | $-6.78 | — |